[1] |
WHO. WHO Global tuberculosis report 2024[EB/OL]. (2024-10-29)[2024-11-15]. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024.
|
[2] |
KAHN S R, DE WIT K. Pulmonary embolism[J]. N Engl J Med, 2022, 387(1):45-57. doi:10.1056/NEJMcp2116489.
|
[3] |
HUANG L, YIN C, GU X, et al. Severe pulmonary tuberculosis complicated with insidious pulmonary thromboembolism:a case report and literature review[J]. J Thromb Thrombolysis, 2020, 49(4):644-650. doi:10.1007/s11239-019-01967-x.
|
[4] |
KERAMIDAS G, GOURGOULIANIS K I, KOTSIOU O S. Venous thromboembolic disease in chronic inflammatory lung diseases:knowns and unknowns[J]. J Clin Med, 2021, 10(10):2061. doi:10.3390/jcm10102061.
|
[5] |
DANWANG C, BIGNA J J, AWANA A P, et al. Global epidemiology of venous thromboembolism in people with active tuberculosis:a systematic review and meta-analysis[J]. J Thromb Thrombolysis, 2021, 51(2):502-512. doi:10.1007/s11239-020-02211-7.
|
[6] |
ALAWAD M J, ALBUNI M K, SUBAHI E A, et al. Rifampicin-induced pulmonry embolism:a rare side effect[J]. Cureus, 2021, 13(10):e18904. doi:10.7759/cureus.18904.
|
[7] |
ZHOU X, YANG Y, ZHAI Z, et al. Clinical characteristics and mortality predictors among very old patients with pulmonary thromboembolism:a multicenter study report[J]. BMC Pulm Med, 2024, 24(1):26. doi:10.1186/s12890-023-02824-7.
|
[8] |
DI BARI V, GUALANO G, MUSSO M, et al. Increased association of pulmonary thromboembolism and tuberculosis during COVID-19 pandemic:data from an Italian infectious disease referral hospital[J]. Antibiotics (Basel), 2022, 11(3):398. doi:10.3390/antibiotics11030398.
|
[9] |
CHEDID C, KOKHREIDZE E, TUKVADZE N, et al. Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study[J]. Int J Infect Dis, 2020, 100:199-206. doi:10.1016/j.ijid.2020.09.017.
|
[10] |
GU Z, LIU B, YU X, et al. Association of blood neutrophil-lymphocyte ratio with short-term prognosis and severity of tuberculosis meningitis patients without HIV infection[J]. BMC Infect Dis, 2023, 23(1):449. doi:10.1186/s12879-023-08438-y.
|
[11] |
SHARIF-KASHANI B, AZIMI M, TABARSI P, et al. Investigation of two general venous thromboembolism risk-stratification models in predicting venous thromboembolic events in TB patients[J]. Int J Mycobacteriol, 2022, 11(1):83-87. doi:10.4103/ijmy.ijmy_252_21.
|
[12] |
FELKER G M, ALLEN L A, POCOCK S J, et al. Red cell distribution width as a novel prognostic marker in heart failure:data from the CHARM Program and the Duke Databank[J]. J Am Coll Cardiol, 2007, 50(1):40-47. doi:10.1016/j.jacc.2007.02.067.
|
[13] |
TONELLI M, SACKS F, ARNOLD M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease[J]. Circulation, 2008, 117(2):163-168. doi:10.1161/CIRCULATIONAHA.107.727545.
|
[14] |
FEBRA C, SPINU V, FERREIRA F, et al. Predictive value for increased red blood cell distribution width in unprovoked acute venous thromboembolism at the emergency department[J]. Clin Appl Thromb Hemost, 2023, 29:10760296231193397. doi:10.1177/10760296231193397.
|
[15] |
MELEKOĞLU A, ÖZKAN S, ÖZTÜRK D. Relationship between hematological parameters and mortality in patients with acute PTE[J]. Global Emergency and Critical Care (Online), 2023, 2(1). doi:10.4274/globecc.galenos.2023.00719.
|
[16] |
JOOSSE H J, VAN OIRSCHOT B A, KOOIJMANS S A A, et al. In-vitro and in-silico evidence for oxidative stress as drivers for RDW[J]. Sci Rep, 2023, 13(1):9223. doi: 10.1038/s41598-023-36514-5.
|
[17] |
YU F T, ARMSTRONG J K, TRIPETTE J, et al. A local increase in red blood cell aggregation can trigger deep vein thrombosis:evidence based on quantitative cellular ultrasound imaging[J]. J Thromb Haemost, 2011, 9(3):481-488. doi:10.1111/j.1538-7836.2010.04164.x.
|
[18] |
GERSH K C, NAGASWAMI C, WEISEL J W. Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes[J]. Thromb Haemost, 2009, 102(6):1169-1175. doi:10.1160/TH09-03-0199.
|
[19] |
ESMON C T, XU J, LUPU F. Innate immunity and coagulation[J]. J Thromb Haemost, 2011, 9(Suppl 1):182-188. doi:10.1111/j.1538-7836.2011.04323.x.
|
[20] |
KAGER L M, BLOK D C, LEDE I O, et al. Pulmonary tuberculosis induces a systemic hypercoagulable state[J]. J Infect, 2015, 70(4):324-334. doi:10.1016/j.jinf.2014.10.006.
|